New EFLM goals for Coagulation: An example analysis of an Atellica 360
We look at the impact of new EFLM goals for coagulation assays on the assessment of an Atellica COAG 360.
We look at the impact of new EFLM goals for coagulation assays on the assessment of an Atellica COAG 360.
A recent study of Abbott Alinity thyroid function tests can be evaluated against the EFLM MAU and the preferred permissible uncertainties proposed by the leading authorities on mu.
A recent study of Roche Cobas 8000 chemistry assays in Turkey looks at their measurement uncertainty. We compare the Roche mu against the EFLM MAU and the preferred permissible uncertainties proposed by the leading authorities on mu.
A recent study of Roche Cobas 6000 c501 chemistry assays looks at their measurement uncertainty. We compare the Roche mu against the EFLM MAU and preferred permissible uncertainties proposed by the leading authorities on mu.
A continuing investigation into assay capability to meet new performance specifications for permissible measurement uncertainty (pU). Can the Atellica CH 930 hit these targets?